Show simple item record

dc.contributor.authorBates, Joshua Philip
dc.date.accessioned2016-06-28T19:14:23Z
dc.date.available2016-06-28T19:14:23Z
dc.date.issued2016
dc.identifier.urihttp://hdl.handle.net/10713/5486
dc.descriptionUniversity of Maryland, Baltimore. Molecular Medicine. M.S. 2016en_US
dc.description.abstractNKT cells are significantly reduced in the blood of newly diagnosed breast cancer (BC) patients compared to healthy volunteers (HV). We hypothesize that one mechanism by which breast cancers escape immune detection is due to a loss in NKT cell number and function. Therefore, we used mice genetically predisposed to develop breast cancer (BRCA1-mut) to examine the phenotype and function of NKT cells throughout tumorigenesis. We found that BRCA1-mut mice have a 70-85% reduction of NKT cells in primary and secondary lymphoid organs, and that this reduction occurs in stage 3 of development. Moreover, the NKT cells of BRCA1-mut mice are functionally altered. Thus, our data suggest that NKT cells play a critical role in the development of breast tumorigenesis and further research is required to determine the mechanisms by which NKT cells are physically and functionally reduced in the absence of BRCA1.en_US
dc.language.isoen_USen_US
dc.subjectBRCA1en_US
dc.subjectNKTen_US
dc.subject.lcshBreast--Canceren_US
dc.subject.meshGenes, BRCA1en_US
dc.subject.meshImmunotherapyen_US
dc.subject.meshNatural Killer T-Cellsen_US
dc.titleDefective Natural Killer T cell development and function in BRCA1 mutant miceen_US
dc.typedissertationen_US
dc.contributor.advisorWebb, Tonya J.
refterms.dateFOA2019-02-21T02:11:45Z


Files in this item

Thumbnail
Name:
Bates_umaryland_0373N_10719.pdf
Size:
1.766Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record